Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Yasui

Showing results (211-220 of 311) with videos related to

Pageof 32
Sort By:
The Journal of Rheumatology|September 18, 1997
Osteoclastogenesis in iliac bone marrow of patients with rheumatoid arthritisY Toritsuka, N Nakamura, S B Lee, et al.
European Journal of Clinical Pharmacology|September 28, 2004
Pharmacokinetic differences between the enantiomers of lansoprazole and its metabolite, 5-hydroxylansoprazole, in relation to CYP2C19 genotypesM Miura, H Tada, N Yasui-Furukori, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|March 2, 2006
Intestinal CYP3A4 is not involved in the enantioselective disposition of lansoprazoleM Miura, H Kagaya, H Tada, et al.
Pharmacogenetics|November 14, 1997
Effects of thioridazine, an inhibitor of CYP2D6, on the steady-state plasma concentrations of the enantiomers of mianserin and its active metabolite, desmethylmianserin, in depressed Japanese patientsN Yasui, G Tybring, K Otani, et al.
Biochemical and Biophysical Research Communications|January 27, 1999
Microphthalmia-associated transcription factor interacts with PU.1 and c-Fos: determination of their subcellular localizationM Sato, E Morii, K Takebayashi-Suzuki, et al.
Pharmacology & Toxicology|June 8, 2001
Effects of genetic polymorphism of CYP1A2 inducibility on the steady-state plasma concentrations of trazodone and its active metabolite m-chlorophenylpiperazine in depressed Japanese patientsK Mihara, T Kondo, A Suzuki, et al.
Journal of Psychopharmacology (Oxford, England)|May 30, 2009
Clinical response to risperidone in relation to plasma drug concentrations in acutely exacerbated schizophrenic patientsN Yasui-Furukori, M Saito, T Nakagami, et al.
European Journal of Clinical Pharmacology|March 27, 1998
Correlation between steady-state plasma concentrations of mianserin and trazodone in depressed patientsK Otani, G Tybring, K Mihara, et al.
Nihon Igaku Hoshasen Gakkai Zasshi. Nippon Acta Radiologica|November 25, 1991
[Magnetic resonance imaging of aneurysmal subarachnoid hemorrhage]T Ogawa, E Shimosegawa, A Inugami, et al.
Psychopharmacology|August 27, 1999
Effects of itraconazole on the steady-state plasma concentrations of bromperidol and reduced bromperidol in schizophrenic patientsH Furukori, T Kondo, N Yasui, et al.
Pageof 32

Showing results (211-220 of 311) with videos related to

Sort By:
Pageof 32
The Journal of Rheumatology|September 18, 1997
Osteoclastogenesis in iliac bone marrow of patients with rheumatoid arthritisY Toritsuka, N Nakamura, S B Lee, et al.
European Journal of Clinical Pharmacology|September 28, 2004
Pharmacokinetic differences between the enantiomers of lansoprazole and its metabolite, 5-hydroxylansoprazole, in relation to CYP2C19 genotypesM Miura, H Tada, N Yasui-Furukori, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|March 2, 2006
Intestinal CYP3A4 is not involved in the enantioselective disposition of lansoprazoleM Miura, H Kagaya, H Tada, et al.
Pharmacogenetics|November 14, 1997
Effects of thioridazine, an inhibitor of CYP2D6, on the steady-state plasma concentrations of the enantiomers of mianserin and its active metabolite, desmethylmianserin, in depressed Japanese patientsN Yasui, G Tybring, K Otani, et al.
Biochemical and Biophysical Research Communications|January 27, 1999
Microphthalmia-associated transcription factor interacts with PU.1 and c-Fos: determination of their subcellular localizationM Sato, E Morii, K Takebayashi-Suzuki, et al.
Pharmacology & Toxicology|June 8, 2001
Effects of genetic polymorphism of CYP1A2 inducibility on the steady-state plasma concentrations of trazodone and its active metabolite m-chlorophenylpiperazine in depressed Japanese patientsK Mihara, T Kondo, A Suzuki, et al.
Journal of Psychopharmacology (Oxford, England)|May 30, 2009
Clinical response to risperidone in relation to plasma drug concentrations in acutely exacerbated schizophrenic patientsN Yasui-Furukori, M Saito, T Nakagami, et al.
European Journal of Clinical Pharmacology|March 27, 1998
Correlation between steady-state plasma concentrations of mianserin and trazodone in depressed patientsK Otani, G Tybring, K Mihara, et al.
Nihon Igaku Hoshasen Gakkai Zasshi. Nippon Acta Radiologica|November 25, 1991
[Magnetic resonance imaging of aneurysmal subarachnoid hemorrhage]T Ogawa, E Shimosegawa, A Inugami, et al.
Psychopharmacology|August 27, 1999
Effects of itraconazole on the steady-state plasma concentrations of bromperidol and reduced bromperidol in schizophrenic patientsH Furukori, T Kondo, N Yasui, et al.
Pageof 32